JULIA BERN: Open Payments
NPI 1407236987 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$225 in 10 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $160 · 2025 $225
Food & beverage: $225
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $51 |
| UCB, Inc. | 2 | $50 |
| Astellas Pharma US Inc | 1 | $30 |
| GE HEALTHCARE | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Bimzelx, Veozah, WaveWriter Alpha Prime 16, General - Pain Management, TZIELD, ORENCIA, Kerendia, Wegovy.
Industry payments across GA — which companies pay providers there.
